Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
| 16 Jan 2022 | |
| Written by Victoria Bastiman | |
| OH News |
Having experienced Covid twice, including long term symptoms, Amitava is now researching the effect of covid long term.
I am leading the team conducting the Stimulate-ICP (Symptoms, trajectory, inequalities and management: understanding long Covid to address and transform existing integrated care pathways) study, which involves a trial to evaluate a community-based, comprehensive MRI scan to rule out multi-organ impairment caused by Covid-19 and digitally enhanced rehabilitation, including tailored information and recovery plans, and connection to relevant specialists through an app, which will inform future care. Another trial will repurpose existing drugs, including antihistamines (loratadine and famotidine), anticoagulants (rivaroxaban) and anti-inflammatories (colchicine) to measure effects of three months’ treatment on long Covid symptoms, mental health, return to work and other important outcomes.
Further details on his research can be found in his article, published in the Guardian:
We wish Amitava luck with his research.
Congratulations to all Old Hymerians who have graduated over the last year More...
Richard Gore, OH 1958-66, wrote the story for his nieces and nephews More...
The first of our pavers have now been laid at the front of Hymers College and we are deli More...
Xiao Yuan Wang, OH 2014-16 told us about her continued studies and new career at the Unive More...
Managing Director of Eyeweb, Paul Scott, OH 1986-96, and his team were raising money for H More...
